A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts

Thomas Yager and colleagues develop and validate a molecular host assay to discriminate between sepsis and infection-negative systemic inflammation in critically ill patients.

Vyšlo v časopise: A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts. PLoS Med 12(12): e32767. doi:10.1371/journal.pmed.1001916
Kategorie: Research Article
prolekare.web.journal.doi_sk: 10.1371/journal.pmed.1001916


Thomas Yager and colleagues develop and validate a molecular host assay to discriminate between sepsis and infection-negative systemic inflammation in critically ill patients.


1. Hsu AA, Fenton K, Weinstein S, Carpenter J, Dalton H, Bell MJ. Neurological injury markers in children with septic shock. Pediatr Crit Care Med. 2008;9:245–251. doi: 10.1097/PCC.0b013e3181727b22 18446104

2. Winters BD, Eberlein M, Leung J, Needham DM, Pronovost PJ, Sevransky JE. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med. 2010;38:1276–1283. doi: 10.1097/CCM.0b013e3181d8cc1d 20308885

3. Bauer M, Reinhart K. Molecular diagnostics of sepsis—where are we today? Int J Med Microbiol. 2010;300:411–413. doi: 10.1016/j.ijmm.2010.04.006 20510650

4. Calandra T, Cohen J. The International Sepsis Forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med. 2005;33:1538–1548. 16003060

5. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2008;36:296–327. 18158437

6. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Intensive Care Med. 2013;39:165–228. doi: 10.1007/s00134-012-2769-8 23361625

7. Coburn B, Morris AM, Tomlinson G, Detsky AS. Does this adult patient with suspected bacteremia require blood cultures? JAMA 2012;308:502–511. doi: 10.1001/jama.2012.8262 22851117

8. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840–851. doi: 10.1056/NEJMra1208623 23984731

9. Forner L, Larsen T, Kilian M, Holmstrup P. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol. 2006;33:401–407. 16677328

10. Lamy B, Roy P, Carret G, Flandrois J- P, Delignette-Muller ML. What is the relevance of obtaining multiple blood samples for culture? A comprehensive model to optimize the strategy for diagnosing bacteremia. Clin Infect Dis. 2002;35:842–850. 12228821

11. Aronson MD, Bor DH. Blood cultures. Ann Intern Med. 1987;106:246–253. 3541726

12. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret G-Y. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34:1996–2003. 16715031

13. Meynaar IA, Droog W, Batstra M, Vreede R, Herbrink P. In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il-6, or LBP. Crit Care Res Pract. 2011;2011:594645. doi: 10.1155/2011/594645 21687569

14. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC. The use of gene-expression profiling to identify candidate genes in human sepsis. Am J Respir Crit Care Med. 2007;176:676–684. 17575094

15. Cruciani M. Meta-analyses of diagnostic tests in infectious diseases: how helpful are they in the intensive care setting? HSR Proc Intensive Care Cardiovasc Anesth. 2011;3:103–108. 23439607

16. Hoenigl M, Raggam RB, Wagner J, Prueller F, Grisold AJ, Leitner E, et al. Procalcitonin fails to predict bacteremia in SIRS patients: a cohort study. Int J Clin Pract. 2014;68:1278–1281. doi: 10.1111/ijcp.12474 24898888

17. Reinhart K, Bauer M, Riedemann NC, Hartog CS. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev. 2012;25:609–634. doi: 10.1128/CMR.00016-12 23034322

18. Shapiro NI, Trzeciak S, Hollander JE, Birkhahn R, Otero R, Osborn TM, et al. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med. 2009;37:96–104. doi: 10.1097/CCM.0b013e318192fd9d 19050610

19. Gibot S, Bene MC, Noel R, Massin F, Guy J, Cravoisy A, et al. Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Resp Crit Care Med. 2012;186:65–71. doi: 10.1164/rccm.201201-0037OC 22538802

20. Venter D, Thomas M, Lipman J, Tang B, McLean A, Pascoe R, et al. A novel molecular biomarker diagnostic for the early detection of sepsis. Crit Care 2010;14 (Suppl 2):P9. doi: 10.1186/cc9112

21. Sutherland A, Thomas M, Brandon RA, Brandon RB, Lipman J, Tang B, et al. Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis. Crit Care 2011;15:R149. doi: 10.1186/cc10274 21682927

22. Brandon RB, Thomas M, Brandon RA, Venter D, Presneill J, Lipman J, et al. A limited set of molecular biomarkers may provide superior diagnostic outcomes to procalcitonin in sepsis. Crit Care 2012;16 (Suppl 3):P40. doi: 10.1186/cc11727

23. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250–1256. 12682500

24. Klein Klouwenberg PM, Ong DS, Bos LD, de Beer FM, van Hooijdonk RT, Huson MA, et al. Interobserver agreement of centers for disease control and prevention criteria for classifying infections in critically ill patients. Crit Care Med. 2013;41:2373–2378. doi: 10.1097/CCM.0b013e3182923712 23921277

25. Klein Klouwenberg PM, van Mourik MS, Ong DS, Horn J, Schultz MJ, Cremer OL, et al. Electronic implementation of a novel surveillance paradigm for ventilator-associated events. Feasibility and validation. Am J Respir Crit Care Med. 2014;189:947–955. doi: 10.1164/rccm.201307-1376OC 24498886

26. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140. 2841893

27. Lockstone HE. Exon array data analysis using Affymetrix power tools and R statistical software. Brief Bioinform. 2011;12.6:634–644. 21498550

28. Huber PJ. Robust statistics. New York: John Wiley and Sons; 1981.

29. Guyon I, Weston J, Barnhill S, Vapnik V. Gene selection for cancer classification using support vector machines. Mach Learn. 2002;46:389–422. doi: 10.1023/A:1012487302797

30. Díaz-Uriarte R, Alvarez de Andrés S. Gene selection and classification of microarray data using random forest. BMC Bioinformatics 2006;7:3. 16398926

31. Helm D, Labischinski H, Schallehn G, Naumann D. Classification and identification of bacteria by Fourier-transform infrared spectroscopy. J Gen Microbiol. 1991;137:69–79. 1710644

32. Clinical and Laboratory Standards Institute. Assessment of the diagnostic accuracy of laboratory tests using receiver operating characteristic curves; approved guideline. 2nd edition. EP24-A2. Wayne (Pennsylvania): Clinical and Laboratory Standards Institute; 2011.

33. Huang SH. Dimensionality reduction in automatic knowledge acquisition: a simple greedy search approach. IEEE Trans Knowl Data Eng. 2003;15.6:1364–1373. doi: 10.1109/TKDE.2003.1245278

34. Venkatraman ES. A permutation test to compare receiver operating characteristic curves. Biometrics 2000;56:1134–1138. 11129471

35. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011;12:77–93. doi: 10.1186/1471-2105-12-77 21414208

36. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837–845. 3203132

37. Gustafson P, Le Nhu D. Comparing the effects of continuous and discrete covariate mismeasurement, with emphasis on the dichotomization of mismeasured predictors. Biometrics 2002;58:878–887. 12495142

38. Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med. 2006;25:127–141. 16217841

39. Naggara O, Raymond J, Guilbert F, Roy D, Weill A, Altman DG. Analysis by categorizing or dichotomizing continuous variables is inadvisable: an example from the natural history of unruptured aneurysms. Am J Neuroradiol. 2011;32:437–440. doi: 10.3174/ajnr.A2425 21330400

40. Caille A, Leyrat C, Giraudeau B. Dichotomizing a continuous outcome in cluster randomized trials: impact on power. Stat Med. 2012;31:2822–2832. doi: 10.1002/sim.5409 22733454

41. Gu W, Pepe MS. Estimating the capacity for improvement in risk prediction with a marker. Biostatistics 2009;10:172–186. doi: 10.1093/biostatistics/kxn025 18714084

42. Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–172. 17569110

43. Kerr KF, Wang Z, Janes H, McClelland RL, Psaty BM, Pepe MS. Net reclassification indices for evaluating risk prediction instruments: a critical review. Epidemiology 2014;25:114–121. doi: 10.1097/EDE.0000000000000018 24240655

44. Leisenring W, Alonzo T, Pepe MS. Comparisons of predictive values of binary medical diagnostic tests for paired designs. Biometrics 2000;56:345–351. 10877288

45. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Chem. 2003;49:1–6. 12507953

46. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem. 2003;49:7–18. 12507954

47. Takahashi W, Watanabe E, Fujimura L, Watanabe-Takano H, Yoshidome H, Swanson PE, et al. Kinetics and protective role of autophagy in a mouse cecal ligation and puncture-induced sepsis. Crit Care 2013;17:R160. doi: 10.1186/cc12839 23883625

48. Huynh KK, Eskelinen EL, Scott CC, Malevanets A, Saftig P, Grinstein S. LAMP proteins are required for fusion of lysosomes with phagosomes. EMBO J 2007;26:313–324. 17245426

49. Lin L, Ayala P, Larson J, Mulks M, Fukuda M, Carlsson SR, et al. The Neisseria type 2 IgA1 protease cleaves LAMP1 and promotes survival of bacteria within epithelial cells. Mol Microbiol. 1997;24:1083–1094. 9220014

50. Endo S, Inada K, Yamashita H, Takakuwa T, Nakae H, Kasai T, et al. Platelet-activating factor (PAF) acetylhydrolase activity, type II phospholipase A2, and cytokine levels in patients with sepsis. Res Commun Chem Pathol Pharmacol. 1994;83:289–295. 8008978

51. Yang J, Xu J, Chen X, Zhang Y, Jiang X, Guo X, et al. Decrease of plasma platelet-activating factor acetylhydrolase activity in lipopolysaccharide induced Mongolian gerbil sepsis model. PLoS ONE 2010;5:e9190. doi: 10.1371/journal.pone.0009190 20169191

52. Gomes RN, Bozza FA, Amancio RT, Japiassu AM, Vianna RC, Larangeira AP, et al. Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. Shock 2006;26:41–49. 16783197

53. Takakuwa T, Endo S, Nakae H, Suzuki T, Inada K, Yoshida M, et al. Relationships between plasma levels of type-II phospholipase A2, PAF-acetylhydrolase, leukotriene B4, complements, endothelin-1, and thrombomodulin in patients with sepsis. Res Commun Chem Pathol Pharmacol. 1994;84:271–281. 7938901

54. Schuster DP, Metzler M, Opal S, Lowry S, Balk R, Abraham E, et al. Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: phase IIb, multicenter, randomized, placebo-controlled, clinical trial. Crit Care Med. 2003;31:1612–1619. 12794395

55. Opal S, Laterre P-F, Abraham E, Francois B, Wittebole X, Lowry S, et al. Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial. Crit Care Med. 2004;32:332–341. 14758145

56. Pankla R, Buddhisa S, Berry M, Blankenship DM, Bancroft GJ, Banchereau J, et al. Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol. 2009;10:R127. doi: 10.1186/gb-2009-10-11-r127 19903332

57. Ledford JG, Kovarova M, Koller BH. Impaired host defense in mice lacking ONZIN. J Immunol. 2007;178:5132–5143. 17404296

58. Johnson RM, Kerr MS, Slaven JE. Perforin is detrimental to controlling C. muridarum replication in vitro, but not in vivo. PLoS ONE 2013;8:e63340. doi: 10.1371/journal.pone.0063340 23691028

59. Johnson RM, Kerr MS, Slaven JE. Plac8-dependent and inducible NO synthase-dependent mechanisms clear Chlamydia muridarum infections from the genital tract. J Immunol. 2012;188:1896–1904. doi: 10.4049/jimmunol.1102764 22238459

60. Wieland S, Thimme R, Purcell RH, Chisari FV. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 2004;101:6669–6674. 15100412

61. Kuroki M, Arakawa F, Matsuo Y, Oikawa S, Misumi Y, Nakazato H, et al. Molecular cloning of nonspecific cross-reacting antigens in human granulocytes. J Biol Chem. 1991;266:11810–11817. 2050678

62. Tascón JD, Adrian J, Kopp K, Scholz P, Tschan MP, Kuespert K, et al. The granulocyte orphan receptor CEACAM4 is able to trigger phagocytosis of bacteria. J Leukocyte Biol. 2015;97:521–531. doi: 10.1189/jlb.2AB0813-449RR 25567962

63. Bos MP, Grunert F, Belland RJ. Differential recognition of members of the carcinoembryonic antigen family by Opa variants of Neisseria gonorrhoeae. Infect Immun. 1997;65:2353–2361. 9169774

64. Klein SL. Sex differences in prophylaxis and therapeutic treatments for viral diseases. Handb Exp Pharmacol. 2012;214:499–522. doi: 10.1007/978-3-642-30726-3_22 23027464

65. Pennell LM, Galligan CL, Fish EN. Sex affects immunity. J Autoimmun. 2012;38:J282–J291. doi: 10.1016/j.jaut.2011.11.013 22225601

66. Gelfand EW. Development of asthma is determined by the age-dependent host response to respiratory virus infection: therapeutic implications. Curr Opin Immunol. 2012;24:713–719. doi: 10.1016/j.coi.2012.08.011 22981683

67. Stoecklein VM, Osuka A, Lederer JA. Trauma equals danger—damage control by the immune system. J Leukocyte Biol. 2012;92:539–551. doi: 10.1189/jlb.0212072 22654121

68. Lang PO, Aspinall R. Immunosenescence and herd immunity: with an ever increasing aging population do we need to rethink vaccine schedules? Expert Rev Vaccines 2012;11:167–176. doi: 10.1586/erv.11.187 22309666

69. Fulop T, Larbi A, Kotb R, de Angelis AF, Pawelec G. Aging, immunity, and cancer. Discov Med 2011;11:537–550. 21712020

70. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med. 1978;299:926–930. 692598

71. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests. J Am Med Assoc. 1999;282:1061–1066. 10493205

72. Mulherin SA, Miller WC. Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation. Ann Intern Med. 2002;137:598–602. 12353947

73. Willis BH. Spectrum bias—why clinicians need to be cautious when applying diagnostic test studies. Fam Pract. 2008;25:390–396. doi: 10.1093/fampra/cmn051 18765409

74. Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004;8:R234–R242. doi: 10.1186/cc2877 15312223

75. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med. 2003;31:1737–1741. 12794413

76. Rey C, Los Arcos M, Concha A, Medina A, Prieto S, Martinez P, et al. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive Care Med. 2007;33:477–484. 17260130

77. van Gestel A, Bakker J, Veraart CP, van Hout BA. Prevalence and incidence of severe sepsis in Dutch intensive care units. Crit Care. 2004;8:R153–R162. doi: 10.1186/cc2858 15312213

78. Pewsner D, Battaglia M, Minder C, Marx A, Bucher HC, Egger M. Ruling a diagnosis in or out with “SpPIn” and “SnNOut”: a note of caution. BMJ. 2004;329:209–213. 15271832

79. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100:1619–1636. 1959406

80. Moreno R, Vincent J-L, Matos R, Mendonca A, Cantraine F, Thijs L, et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med. 1999;25:686–696. 10470572

81. Cook R, Cook DJ, Tilley J, Lee K, Marshall J. Multiple organ dysfunction: baseline and serial component scores. Crit Care Med. 2001;29:2046–2050. 11700393

82. Braykov NP, Morgan DJ, Schweizer ML, Uslan DZ, Kelesidis T, Weisenberg SA, et al. Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study. Lancet Infect Dis. 2014;14:1220–1227. doi: 10.1016/S1473-3099(14)70952-1 25455989

83. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AA, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644–1655. 1303622

84. Nathan C. Points of control in inflammation. Nature 2002;420:846–852. 12490957

85. Nathan C, Ding A. Non-resolving inflammation. Cell 2010;140:871–882. doi: 10.1016/j.cell.2010.02.029 20303877

Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine

2015 Číslo 12
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Zabudnuté heslo

Nemáte účet?  Registrujte sa

Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.


Nemáte účet?  Registrujte sa